Hematologic Neoplasm Associated with Down Syndrome — knowledge graph · CancerIndex

Knowledge graph · Cancer

Hematologic Neoplasm Associated with Down Syndrome

hematologic malignancy

Identifier: CI-CAN-00005464
Entity page: /cancer/hematologic-neoplasm-associated-with-down-syndrome ↗
Edges: 13

Neighbours: 8 drugs5 trials
Drawn: 13 of 13 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Hematologic Neoplasm Associated with Down Syndrome investigated in trials for …INVESTIGATED_IN_TRIALSderived8 of 8
→ investigated in trials for	Cytarabinesmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Hematologic Neoplasm Associated with Down Syndrome	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Asparaginaseother 1 trials (1 active) · roll-up of the cancer and its descendants

Hematologic Neoplasm Associated with Down Syndrome studied in …STUDIED_INderived5 of 5
→ studied in	NCT04726241Phase 1/Phase 2 · recruiting The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study · condition mapped ONTOLOGY_EXACT · 5 trials mapped (4 active)	—	—	Myeloid Leukemia Associated with Down Syndrome	1	Observed	clinicaltrials	graph →
→ studied in	NCT05702645recruiting A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia · condition mapped ONTOLOGY_EXACT · 5 trials mapped (4 active)	—	—	Myeloid Leukemia Associated with Down Syndrome	1	Observed	clinicaltrials	graph →
→ studied in	NCT02521493Phase 3 · active not recruiting Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome · condition mapped ONTOLOGY_EXACT · 5 trials mapped (4 active)	—	—	Myeloid Leukemia Associated with Down Syndrome	1	Observed	clinicaltrials	graph →
→ studied in	NCT05146739Phase 1 · active not recruiting Highest Dose of Uproleselan in Combination With Fludarabine and Cytarabine for Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Mixed Phenotype Acute Leukemia Relapsed or Refractory That Expresses E-selectin Ligand on the Cell Membrane · condition mapped ONTOLOGY_EXACT · 5 trials mapped (4 active)	—	—	Myeloid Leukemia Associated with Down Syndrome	1	Observed	clinicaltrials	graph →
→ studied in	NCT05717634unknown Endometrial Changes in Breast Cancer Women. · condition mapped ALIAS · 5 trials mapped (4 active)	—	—	Transient Abnormal Myelopoiesis Associated with Down Syndrome	1	Observed	clinicaltrials	graph →